Analyst Price Target is $4.50
▲ +48.03% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Ovid Therapeutics in the last 3 months. The average price target is $4.50, with a high forecast of $5.00 and a low forecast of $4.00. The average price target represents a 48.03% upside from the last price of $3.04.
Current Consensus is
The current consensus among 5 contributing investment analysts is to hold stock in Ovid Therapeutics. This rating has held steady since November 2020, when it changed from a Buy consensus rating.